https://www.fda.gov/drugs/accelerated-approval-program/withdrawn-non-malignant-hematological-neurological-and-other-disorder-indications-accelerated
This listing includes accelerated approvals (AAs) for non-malignant hematological, neurological, and other disorder indications with postmarketing trials that...
withdrawnnonmalignanthematologicalneurological
https://pubmed.ncbi.nlm.nih.gov/26435669/?dopt=Abstract
NAID is common in early childhood and is associated with modifiable risk factors. Substantial practice variation exists in the management of NAID. Further...
risk factorspracticevariationhematologicaloutcomes
https://www.als-journal.com/1149-24/
Full Length Research Article Impact of varying sorbitol concentrations on hematological and biochemical blood parameters in Wistar rats (Rattus norvegicus) ...
impactvaryingsorbitolconcentrationshematological